185 related articles for article (PubMed ID: 10999048)
1. Malignant melanoma and the sentinel lymph node biopsy.
Kuhn JA; McCarty TM
Cancer Invest; 1999; 17(1):39-46. PubMed ID: 10999048
[No Abstract] [Full Text] [Related]
2. Lymphatic mapping and sentinel node biopsy in patients with malignant melanoma.
Reintgen D; Rapaport D; Tanabe KK; Ross M
J Fla Med Assoc; 1997 Mar; 84(3):188-93. PubMed ID: 9143171
[TBL] [Abstract][Full Text] [Related]
3. [The sentinel lymph node in melanoma: utilization of molecular biology (RT-PCR) to detect occult metastases].
Riccioni L; Farabegoli P; Nanni O; Morigi F; Polverelli M; Landi G; Giangaspero F
Pathologica; 2002 Aug; 94(4):190-5. PubMed ID: 12325417
[TBL] [Abstract][Full Text] [Related]
4. Selective lymph node dissection in patients with intermediate thickness melanoma: our experience.
Cafiero F; Peressini A; Percivale PL; Rainero ML; Faggioni M; Gipponi M; Queirolo P; Nicolo G; Bertoglio S
Anticancer Res; 2000; 20(1B):497-500. PubMed ID: 10769712
[TBL] [Abstract][Full Text] [Related]
5. Sentinel lymph node metastasis in anal melanoma: a case report.
Tien HY; McMasters KM; Edwards MJ; Chao C
Int J Gastrointest Cancer; 2002; 32(1):53-6. PubMed ID: 12630771
[TBL] [Abstract][Full Text] [Related]
6. Molecular staging of malignant melanoma: correlation with clinical outcome.
Shivers SC; Wang X; Li W; Joseph E; Messina J; Glass LF; DeConti R; Cruse CW; Berman C; Fenske NA; Lyman GH; Reintgen DS
JAMA; 1998 Oct; 280(16):1410-5. PubMed ID: 9801000
[TBL] [Abstract][Full Text] [Related]
7. Molecular Staging of Sentinel Lymph Nodes Identifies Melanoma Patients at Increased Risk of Nodal Recurrence.
Kimbrough CW; Egger ME; McMasters KM; Stromberg AJ; Martin RC; Philips P; Scoggins CR
J Am Coll Surg; 2016 Apr; 222(4):357-63. PubMed ID: 26875070
[TBL] [Abstract][Full Text] [Related]
8. Triple-marker PCR assay of sentinel lymph node as a prognostic factor in melanoma.
Ito T; Wada M; Nagae K; Nakano-Nakamura M; Nakahara T; Hagihara A; Furue M; Uchi H
J Eur Acad Dermatol Venereol; 2015 May; 29(5):912-8. PubMed ID: 25199412
[TBL] [Abstract][Full Text] [Related]
9. [To outwit melanoma with its own tricks].
Bischoff A
MMW Fortschr Med; 2003 Apr; 145(15):4-6, 8, 10. PubMed ID: 15104255
[No Abstract] [Full Text] [Related]
10. Clinical relevance of sentinel lymph node status examined with conventional histology and molecular biology.
Micciolo R; Boi S; Paoli L; Cristofolini P; Girlando S; Dalla Palma P; Cristofolini M
Tumori; 2009; 95(3):298-302. PubMed ID: 19688967
[TBL] [Abstract][Full Text] [Related]
11. Minimally invasive staging of patients with melanoma: sentinel lymphadenectomy and detection of the melanoma-specific proteins MART-1 and tyrosinase by reverse transcriptase polymerase chain reaction.
Goydos JS; Ravikumar TS; Germino FJ; Yudd A; Bancila E
J Am Coll Surg; 1998 Aug; 187(2):182-8; discussion 188-90. PubMed ID: 9704966
[TBL] [Abstract][Full Text] [Related]
12. [The detection of melanoma metastases in sentinel nodes by polymerase chain reaction].
Poelman M; van der Velde-Zimmermann D; van Doorn LJ; Quint WG; van Krimpen C; de Graaf PW
Ned Tijdschr Geneeskd; 1998 Apr; 142(16):905-8. PubMed ID: 9623187
[TBL] [Abstract][Full Text] [Related]
13. Expression of tyrosinase, MIA and MART-1 in sentinel lymph nodes of patients with malignant melanoma.
Hochberg M; Lotem M; Gimon Z; Shiloni E; Enk CD
Br J Dermatol; 2002 Feb; 146(2):244-9. PubMed ID: 11903234
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of molecular staging study of sentinel lymph nodes by reverse transcriptase-polymerase chain reaction for tyrosinase in melanoma patients.
Mangas C; Hilari JM; Paradelo C; Rex J; Fernández-Figueras MT; Fraile M; Alastrue A; Ferrándiz C
Ann Surg Oncol; 2006 Jul; 13(7):910-8. PubMed ID: 16788751
[TBL] [Abstract][Full Text] [Related]
15. Detection of microscopic melanoma metastases in sentinel lymph nodes.
Yu LL; Flotte TJ; Tanabe KK; Gadd MA; Cosimi AB; Sober AJ; Mihm MC; Duncan LM
Cancer; 1999 Aug; 86(4):617-27. PubMed ID: 10440689
[TBL] [Abstract][Full Text] [Related]
16. Prospective evaluation of selective lymph node biopsy for cutaneous malignant melanoma.
Loggie BW; Hosseinian AA; Watson NE
Am Surg; 1997 Dec; 63(12):1051-7; discussion 1057-8. PubMed ID: 9393252
[TBL] [Abstract][Full Text] [Related]
17. The tumor biology of melanoma nodal metastases.
Miliotes G; Albertini J; Berman C; Heller R; Messina J; Glass F; Cruse W; Rapaport D; Puleo C; Fenske N; Petsoglou C; Deconti R; Lyman G; Reintgen D
Am Surg; 1996 Jan; 62(1):81-8. PubMed ID: 8540654
[TBL] [Abstract][Full Text] [Related]
18. Blue dye and 99mTc-labeled human serum albumin: sentinel node detection by magic bullets?
Wallace AM; Vera DR; Stadalnik RC
J Nucl Med; 1999 Jul; 40(7):1149-50. PubMed ID: 10405135
[No Abstract] [Full Text] [Related]
19. Sentinel-node biopsy or nodal observation in melanoma.
Morton DL; Thompson JF; Cochran AJ; Mozzillo N; Elashoff R; Essner R; Nieweg OE; Roses DF; Hoekstra HJ; Karakousis CP; Reintgen DS; Coventry BJ; Glass EC; Wang HJ;
N Engl J Med; 2006 Sep; 355(13):1307-17. PubMed ID: 17005948
[TBL] [Abstract][Full Text] [Related]
20. [Cutaneous malignant melanoma of the head and neck with intermediate tumor thickness: the role of elective lymph node dissection for clinical stage I].
Wenzel S; Sagowski C; Neuber K; Kehrl W; Metternich FU
Laryngorhinootologie; 2003 Jan; 82(1):19-24. PubMed ID: 12548460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
